Page last updated: 2024-10-24

regulation of timing of neuron differentiation

Definition

Target type: biologicalprocess

The process controlling the activation and/or rate at which a relatively unspecialized cell acquires features of a neuron. [GOC:dph]

The regulation of timing of neuron differentiation is a complex process involving a delicate interplay of intrinsic and extrinsic cues. It is crucial for the proper development of the nervous system, ensuring that neurons arise at the correct time and in the appropriate location.

**Intrinsic Factors:**

* **Transcription factors:** Master regulators of gene expression, including bHLH factors like Neurogenin 2 and NeuroD1, regulate the transition of neural progenitors to post-mitotic neurons. These factors activate neuronal genes and repress progenitor-specific genes.
* **MicroRNAs:** Small non-coding RNAs that fine-tune gene expression. Specific microRNAs have been shown to promote or suppress neuronal differentiation by targeting key regulatory molecules.
* **Epigenetic modifications:** Chemical changes to DNA and histones that influence gene accessibility and activity. These modifications, such as DNA methylation and histone acetylation, contribute to the temporal control of neuronal differentiation.

**Extrinsic Factors:**

* **Growth factors:** Molecules secreted by surrounding cells that stimulate proliferation, survival, and differentiation of neural progenitors. Examples include fibroblast growth factor (FGF), epidermal growth factor (EGF), and nerve growth factor (NGF).
* **Extracellular matrix:** The structural framework surrounding cells, composed of proteins and other molecules. Specific components of the extracellular matrix, such as laminin and collagen, can influence neuronal differentiation by providing adhesion sites and signaling cues.
* **Cell-cell interactions:** Direct contact between cells can also regulate neuron differentiation. For example, interactions with glial cells, such as astrocytes, can influence the timing of neuronal differentiation.

**Timing Control:**

* **Temporal gradient of signaling molecules:** The concentration of growth factors and other signaling molecules can vary over time, creating a temporal gradient that influences neuronal differentiation.
* **Sequential activation of transcription factors:** Transcription factors are often activated in a specific order, ensuring the proper progression of neuronal differentiation.
* **Feedback loops:** Positive and negative feedback loops can amplify or dampen signaling pathways, contributing to the precise regulation of timing.

**Consequences of Dysregulation:**

* **Neurodevelopmental disorders:** Disruptions in the timing of neuronal differentiation can lead to developmental disorders such as autism spectrum disorder, intellectual disability, and epilepsy.
* **Neurodegenerative diseases:** Abnormal timing of neuronal differentiation may contribute to age-related neurodegenerative diseases like Alzheimer's disease and Parkinson's disease.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Nuclear receptor subfamily 2 group E member 1A nuclear receptor subfamily 2 group E member 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y466]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
propafenonepropafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
aromatic ketone;
secondary alcohol;
secondary amino compound
anti-arrhythmia drug
propranololpropranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
naphthalenes;
propanolamine;
secondary amine
anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
dexpropranololpropranolol
tryptolinetryptoline: neurotoxic factor that may be involved in development of Parkinson's disease; enzymatic prep from human brain converts tryptamine to tryptoline; RN given refers to parent cpd; structurebeta-carbolines
tadalafilbenzodioxoles;
pyrazinopyridoindole
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
n-desisopropylpropranololN-desisopropylpropranolol: RN given refers to parent cpd